Viewing Study NCT02173457


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-02-27 @ 10:01 AM
Study NCT ID: NCT02173457
Status: COMPLETED
Last Update Posted: 2019-10-25
First Post: 2014-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module